A common notion amongst every weight watcher is that multigrain bread is better than ice cream. However, a new study from Tufts University has created a “Food Compass” that ranks food items based on a ...
Top 3 High-Momentum Companies Analysts Are Still Bullish On Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom ...
Compass Therapeutics, Inc. (NASDAQ:CMPX) announced statistically significant topline data on Tuesday on the primary efficacy endpoint for COMPANION-002, the company’s ongoing Phase 2/3 trial of ...
Shares of Compass Pathways PLC climbed on Friday after the U.S.-listed healthcare group announced a successful follow-up study of a psychedelic drug used to treat major depression in cancer patients.
ALLSCHWIL/BASEL, SWITZERLAND - 17 March 2014 - Actelion Ltd (ATLN.VX) today announced the results of COMPASS-2, a Phase IV, prospective, randomized, double-blind, placebo-controlled, event-driven ...
Completed enrollment of the planned 150 patients in COMPANION-002, a Phase 2/3 trial of CTX-009 plus paclitaxel versus paclitaxel in patients with previously treated, unresectable advanced Metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results